Scheme 1From: Efficient delivery of the lncRNA LEF1-AS1 through the antibody LAIR-1 (CD305)-modified Zn-Adenine targets articular inflammation to enhance the treatment of rheumatoid arthritisSchematic diagram of the (Zn-Adenine)@Ab NPs delivering LEF1-AS1 to inhibit PI3K/AKT signaling pathway in RA therapyBack to article page